Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-09-05 | New | $47,230,787 | Unknown | Equity Only | SEC link | |
| 2024-11-20 | Amended | $385,850,004 | $162,500,002 | Equity Only | 06b | SEC link |
| 2024-03-26 | Amended | $223,350,002 | $191,850,003 | Equity Only | 06b | SEC link |
| 2022-09-29 | New | $31,499,999 | $31,499,999 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Athena Countouriotis | Director, Executive |
| Jakob Dupont, M.D., M.A. | Director |
| Simeon George | Director |
| Carl Gordon | Director |
| Mohammad Hirmand | Executive |
| Judith Li | Director |
| Scott Lipman | Executive |
| Patrick Machado | Director |
| Garry Nicholson | Director |
| Michael Rome | Director |
| Brian Sun | Executive |
| Paolo Tombesi | Executive |